SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Nov-22 2:07 PM View: | Merus N.V. (MRUS) | 03-Nov-22 | Private Purchase (Planned) | 14,706 | $14.38 | $211,431.00 | 23% 63.37K to 78.07K | |
23-Aug-22 4:09 PM View: | Merus N.V. (MRUS) | 22-Aug-22 | Private Purchase (Planned) | 5,826 | $22.92 | $133,558.00 | 29% 20.04K to 25.87K | |
22-Aug-22 3:02 PM View: | Merus N.V. (MRUS) | 19-Aug-22 | Private Purchase (Planned) | 704 | $22.99 | $16,186.90 | 4% 19.34K to 20.04K | |
13-Jul-22 10:13 AM View: | Merus N.V. (MRUS) | 12-Jul-22 | Private Purchase (Planned) | 4,340 | $22.97 | $99,684.60 | 29% 15.0K to 19.34K | |
04-Aug-21 3:56 PM View: | Merus N.V. (MRUS) | 02-Aug-21 | Option Exercise | 15,000 | $13.36 | $200,474.00 | 100% 0 to 15.0K | |
29-Mar-21 7:18 PM View: | Merus N.V. (MRUS) | 25-Mar-21 | Gift | 74,000 | -- | -- | (40%) 185.5K to 111.5K | |
03-Mar-21 4:00 PM View: | Merus N.V. (MRUS) | 01-Mar-21 | Option Exercise | 74,000 | $13.38 | $989,867.00 | 100% 0 to 74.0K | |
10-Feb-17 2:16 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Conversion | 55,217 | -- | -- | 6% 955.21K to 1.01M | |
10-Feb-17 2:16 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Purchase | 400 | $14.00 | $5,600.00 | < 1% 1.01M to 1.01M |